A Kinetic Model ofthe Erytbron [Summary] Autoradiographic investigations-on humnan bonemarrow cells in vitro have provided information on the cell cycle, rates of hemoglobin, nucleic acid and protein synthesis of nucleated red cells. This information, correlated with other available data (daily red cell production, 5Fe appearance curve, bone-marrow differential count, and total marrow erythroid cellularity) made possible the construction of a kinetic model of the erythron. The results have been published in detail elsewhere (Lajtha & Oliver 1960).
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Observations
(1) Intermitotic cycle: The intermitotic cycle time for the early normoblasts (proand basophilic normoblasts) was measured both -with a DNA labelli g method and by the SFe gain count halving time, and was found to be about twenty hours. The early polychromatic normoblastS appear to have a slightly longer cycle time (approximately thirty hours), and the later polychromatic normoblastsalthough some maintain a vestige of: DNA synthetic capacitydo not appear to divide.
(2) J-kmoglobin synthesis: All nucleated red. cells are capable of "Fe uptake (perhaps apart from the, classical orthochromatic normoblast) but the rate of 59Fe uptake decreases with increasing differentiation. Thus if the uptake rate in pronormoblasts is equated with 0 5, then it decreases to 0,3 in the early polychromatic normoblasts and to 0-25 in the later polychromatic normoblasts. These rate-figures (i.e. 0 5 instead of 1 0) have been chosen as if they are expressed as tipg Hb/hour; they can indicate the expected Hb content of cells, which can be measured independently by the UV absorption of 4,047 A. Thus it is known, that the average Hb content of the basophilicnormoblasts is about 16 ppg, and that of a mature reticulocyte 30 ppg.
(3) Rate changes during cell cycle: Grain count distribution studies have indicated that the rate of Hb synthesis (59Fe uptake) increases exponentially during interphaseparallel with increase in cell -mass. This offered an explanation for the observation of appearance of some very highly labelled reticulocytes, shortly after in vivo 59Fe labelling. These 'high' reticulocytes were suggested as the result of 'skipping' the last mitosis in the early polychromatic normoblast stage. (4) Stem cells: The lack of direct effect of erythropoietin on erythroid cels both in vitro and in vivo, and the' gradual dilution with time of a labelled prondrmoblast population with iinlabelled cells indicated the existence of a precursor (stem cell) compartment, from which, due to proper -stimulation, cells' differentiate' into the erythron.
The Model From the above observations the;consu tion of a model was attempted. For the contstruction certain additional available information had,to be used, i.e. the bone-marrow erythroid. differeintial count, and the time scale of the 59Fe appearance curve in the peripheral blood. 'This model.is illustrated in Fig 1. As with every model, it is required to fit with all the available iinformation on the kinetics of erythropoiesis...As presented above, it incorporates the stem cell comrpartment, from which.a.apronormoblast differentiates oj.t, This cell is .represented as undergoing three twenty-hour cellcycles, gradually increasing its hamoglobin content;.In the first two cycles the cell; morphology-changes ,but little, and differentiation between 'proopormoblast' and basophilic normoblast may partly depend on cell size. With increase in Hb content the cell eventually will be called-'early polychromatic', by which time itscycle time is longer, .and after the last division it matures untiT.the .nucleus is lost and a further periodd of maturation (as, reticulocyte). follows, before. it is. released. into the blood. As 'accidents' are bound to happen in every biological system, a certain amount of cell death will result in some 'ineffective erythropoiesis'. Furthermore, it is postulated that some cells may 'skip' the last mitosis (? reaching a critical Hb concentration which prevents further nuclear functionsa process which could be responsible for nuclear loss also) and then appear earlier in ,the blood, and with a high degree of labelling.
From the scheme the rate of delivery of cells (and of 5Fe, for example) to the blood can be calculated, and the expected rate of 5Fe-appearance is in fact identical with that found in man.
The mitotic index, and differential distribution of cells also can be calculated from the model, and are again the same as found in man.
According to the model one stem cell differentiating into the erythron would produce 20 reticulocytes on the average. Between the stem cell and the reticulocytes there are' 1,517 'hour-s worth' of nucleated cells. From this, and from the daily red cell production the total marrow cellularity can be'calculated. Such a calculation gives 3 x 1011 cells, in good agreement with that found by direct easurement in vivo.
Regulation Kinetics
Apart from the steady state of erythropoiesis, the model offers explanation of the mechanism of regulation oferythropoiesis.
It is suggested that a certain concentration of erythropoietin induces differentiation in a certain proportion of the stem cells (perhaps by enzyme induction). Thus increase of red -cell production by factors of 2 to 8 could be imagined by a 2-to 8-fold increase of the 'feed' of stem cells into the erythron. The same mechanism (induction or stimulation of Hb-synthesizing enzymes) would favour the 'short-cut' pathway (II' on Fig 1) thus resulting in a steeper "Fe appearance curve, and appearance in the blood of some orthochromatic -norxoblasts.
It is expected that the stem cell compartment has its own regulatory feed-back control (? total stem mass) and that there is, in the human body, a supply in significant excess of the daily differentiation, e.g. 5 x 109 stem cells differentiate daily, so that if there are 5 x 1010 stem cells in the compartment (ten days' supply) each day 1/10 of the population will divide to supplement the loss.
This concept avoids postulating an asymnmetric 12' Section ofExperimental Medicine and Therapeutics 371 division and maintains the rule: each daughter cell is a replica of the mother cell.
This model explains the well-known response to ionizing radiations: immediate fallabortive recoverysecond fallrecovery. The majority of the marrow cells are the 'marrow cells proper', the stem compartment (5 x 1010) is only 5% of the total population (1012). Hence a temporary inhibition of mitosis is sufficient to affect the multiplying marrow cell population, as maturation (i.e. leaving the marrow) remains unaffected. This results in the initial fall. On recoveryfrom the mitotic delay the population number increases ('abortive recovery') but as a large proportion of cells will die after the first or second mitosis, this 'abortive recovery' is followed by a second fall in numbers. Only when the integer proportion of the stem cells have recovered will a full regeneration follow.
The pathogenesis of polycythemia: A slow increase in the size of the stem compartment ('benign tumour') will increase red cell production, ifas postulatederythropoietin removes a certain fixed proportion. This would imply that there is a minimal level of erythropoietin production even in polycythemia. Furthermore a greatly increased stem-cell compartment (advanced case) may even stimulate erythropoietin productionexplaining some of the cases of polycythmmia with increased erythropoietin levels. Splenomegaly may be an indication of the increased stem compartment (? reticulum cells, ? blast cells) and therefore radiation of the spleen alone, but certainly total body radiation or mustard treatment, by reducing the stem compartment size, may produce prolonged remission. Massive venesection, by removing large numbers of stem cells (temporarily increased erythropoietin level) also could produce remission.
It would be too far-reaching to speculate on the pluripotentiality of the stem cells, i.e. chronic myeloid leukxemia resulting from increased stem compartment stimulating a hypothetical 'myelopoietin' (after an initial phase of polycythemia)or to speculate that partial or complete loss of differentiating capacity ('malignant' change) may result in subacute (promyelocytic, or di Guglielmo) or acute (blast cell) leukwmia. A great deal of experimentation is needed, but it is hoped that the model will offer itself for experimental testing and will suggest further experiments. With this it will have fulfilled its role of a useful model. The concept that erythropoiesis is under humoral control dates from 1906, when Carnot & Deflandre reported that the red cell count of rabbits was increased if the animals were injected with serum taken from rabbits which had previously been made anemic by bleeding. Reissmann (1950) provided sound experimental support for this theory of hormonal control. He showed that if one member of a pair of parabiotic rats was made hypoxic, then the bone-marrow of both animals showed erythroid hyperplasia. In these experiments, oxygen lack could not have been the direct stimulus which affected the bone-marrow of both animals as the arterial oxygen saturation was normal in one member of each pair. This stimulation of a normal bone-marrow exposed to a normal oxygen tension could be explained by the presence of an erythropoietic factor in the plasma. Much of the experimental work on stimulation of erythropoiesis has been carried out in rodents so the extension of these studies to man and other primates was an important step. In 1954 Stohlman et al. described a patient with regional hypoxia in whom the upper limbs and sternal marrow received fully oxygenated blood, whilst the lower limbs and iliac marrow received blood with an oxygen saturation of only 62%. Bone-marrow from sternum and iliac crest was hypercellular and showed normoblast hyperplasia. Again, in this case, a hormonal factor was available to bonemarrow at both sites. The name erythropoietin has been given to this factor which produces stimulation of the erythroid marrow. Further evidence for its effect in primates was obtained by Van Dyke in 1960. He showed that injection of material obtained from the urine of an anemic human patient induced an increase in the circulating red cell mass of an adult monkey. In one monkey, treatment with erythropoietic material over a period of fifteen days resulted in an increase of 78 % in the total circulating red cell volume.
REFERENCE
In general, it is found that severely anaemic animals and humans have significant amounts of erythropoietin in their plasma and urine (Hodgson & Toha 1954 , Van Dyke et al. 1957 . These are the main sources of the erythropoietin which has been used for investigation and purification. The urinary material is less stable than plasma erythropoietin but at present there is little evidence to suggest that these two materials are not identical. A highly purified preparation of erythropoietin has been prepared from anemic sheep plasma (White et al. 1957 , White et al. 1Beit Memorial Research Fellow 1960 . This material gives an ultraviolet absorption curve typical of protein, it migrates as a single peak in free electrophoresis at pH 4-5 and at pH 8 -6, it has a molecular weight of about 39,000 and its biological activity is lost during treatment with trypsin or chymotrypsin. However, they,present some evidence that this is not yet thepure hormone. Erythropoietin has been concentrated-from the plasma and urine of aniemic rabbits (Hodgson etal. 1958 ,Lowy, Keighley &Borsook 1958 ,Lowy, Keighley, Borsook & Graybiel 1958 , Rambach et al. 1957 , Rambach et al. 1958 . Here, too, the erythropoietic activity is associated with a mucoprotein or polypeptide. It remains to be seen whether there are significant differences between the erythropoietins derived from different species and whether there is species specificity. in responsiveness to erythropoietin (Yoffey 1959 , Gordon 1960 , Van Dyke-1960 .
The probable mechanism and site of action of erythropoietin has been considered by Dr-Lajtha in the preceding paper. Administration of erythropoietin to an intact animal results in an orderly sequence of events (Gordon et al. 1954 , White et al. 1960 ). In the bone-marrow increased numbers of pro-erythroblasts and then normoblasts appear; later, in the peripheral blood, there is a reticulocytosis and ultimately, in the normal animal, an increase in the total circulating red cell mass. Most methods of detection and estimation of erythropoietin are based upon observation of these effects and depend on measurement of either hiemoglobin synthesis or cell division and maturation. These parameters are not the same, and the various methods listed in Table 1 may measure one or a mixture of several biological activities. The measurements in most general use are increase in reticulocytes in normal rats or polycythemic mice and incorporation of 59Fe into red -cells of starved or polycythwemic rats and polycythaemic mice. In -animals prepared by one of these methods, red cell formation and haemo-globin synthesis are depressed and there is a low base line from which to measure stimulation of erythropoiesis ). I use a method which Dr Bangham and I have already described (Cotes & Bangham 1960) . This is observation of stimulation of incorporation of 59Fe into. red cells of mice made polycythamic by exposure to air at half an atmosphere pressure for two weeks. We selected this method because -the polycythaemic animal is more sensitive than normal, it is a preparation which should measure *the erythropoietic stimulus more specifically than a starved animal, and the animals have produced ,their own polycythemia by a physiological Wmethod which avoids the labour and cost of transfusion and may lessen immunological ,hazards. This system is at least as sensitive as. .other in vivo methods, but in common with them its sensitivity is poor. With small groups of animals it is possible to detect a fourfold change in erythropoietic activity.
The erythropoietin concentration in plasma and urine has been estimated by several investigators. The exact significance of the level of erythropoietin in plasma is uncertain for the level of erythropoietin depends upon its rate of formation and upon the. rate at which it is removed from the plasma; this latter is controlled by utilization or destruction and by urinary excretion. In plasma of. normal human subjects, erythropoietin is present in very low concentration (Gurney et al. 1957) . Greatly increased amounts have been detected in plasma from most cases of aneemia and from some cases with polycythamia (see Table 2 ). In an anemic subject, correction of the aneemia is -associated with a fall in the plasma level of erythrQopoietin. There is one group of patients in whonr the plasma erythropoietin level is high and who have polycythemia secondary to renal disease or to a tumour. These tumours include hypernephromata, uterine fibromyomata and cerebellar hiemangiomata. In cases where the (b) Increase in incorporation of Plzak et al. (1955) , Hodgson et al. (1958) , ""Fe irnto red cells Gurney & Pan (1958) 2 Cell division and maturation (a) Increase in total number of Gordon et al. (1954) , see circulating red cells (b, Change in the differential cell Matoth et al. (1958) , , count of bone-marrow Rosse & Gurney (1959) (c) Increase of stathmokinetic index Matoth & Ben-Porath (1959) , Smith (1961) in bone-marrow (d) Increase of "Puptake by DNA Linkenheimer et al. (1959) ofhmmopoietic tissue (e) Increase in reticulocyte count Erslev (1957) , Jacobson et al. (1957) , in peripheral blood Gordon (1960) Myeloid metaplasia with polycyth2mia I Myeloid metaplasia with an&emia 1 *These values may be above or below the normal levels since normal levels are not detectable in these systems a I am grateful to Professor W S Peart who gave me the opportunity to study this patient plasma erythropoietin level was measured before and after removal of the tumour, after operation the erythropoietin level fell and there was regression of the polycythEemia (Jones eta:'. 1960 ). We know little about the site or sites of production of erythropoietin. The kidney seems to be involved. Plasma from patients with uramic anemia does not show the high level of erythropoietin which we consistently find in plasma from patients with other kinds of anemia of comparable severity. And, with most assay methods, no erythropoietin is detectable in plasma from patients with urwmic anemia. Osnes (1959) , who studied mice with an irradiation nephritis, suggested that there are two erythropoietins, one renal and the other non-renal in origin. He explains the anmmia of renal disease by deficiency of the renal factor. Further evidence of renal involvement comes from studies of red cell formation and of erythropoietin formation in nephrectomized animals. Experimental animals of different strains and species vary in their ability to tolerate nephrectomy and this may account for the diversity of results obtained in different investigations. In nephrectomized rats exposed to hypoxia, Jacobson found that the plasma erythropoietin level does not increase to the same extent as in normal animals (Goldwasser et a!. 1958) ; this is in contrast to a report from Mirand & Prentice (1957) who found that erythropoietin formation continued after nephrectomy. In rabbits, nephrectomy does not immediately abolish the ability to form erythropoietin although this ability later disappears (Erslev 1959) . In dogs, nephrectomy greatly reduced red cell formation and Naets (1958 and Naets ( , 1959 could not detect erythropoietin production in nephrectomized dogs after bleeding. The exact role of the kidney in erythropoiesis is still obscure and these experiments neither show us whether erythropoietin is formed in the kidney nor whether the presence of the kidney is essential for formation of erythropoietin at some other site or sites.
There are many other gaps in our understanding of the control of erythropoiesis. We know little about the sensitive centres which set in motion the events which lead to secretion of erythropoietin nor do we know how erythropoietin activates the bone-marrow. The physiological importance of a hormone which specifically stimulates the production of one clone of cells is well recognized, it remains to be seen whether erythropoietin will become a useful therapeutic tool.
